Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis
Open Access
- 19 August 2017
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (8) , 1808
Abstract
Inflammation can be induced by chronic infection, inflammatory diseases and physicochemical factors. Chronic inflammation is estimated to contribute to approximately 25% of human cancers. Under inflammatory conditions, inflammatory and epithelial cells release reactive oxygen (ROS) and nitrogen species (RNS), which are capable of causing DNA damage, including the formation of 8-oxo-7,8-dihydro-2′-deoxyguanosine and 8-nitroguanine. We reported that 8-nitroguanine was clearly formed at the sites of cancer induced by infectious agents including Helicobacter pylori, inflammatory diseases including Barrett’s esophagus, and physicochemical factors including asbestos. DNA damage can lead to mutations and genomic instability if not properly repaired. Moreover, DNA damage response can also induce high mobility group box 1-generating inflammatory microenvironment, which is characterized by hypoxia. Hypoxia induces hypoxia-inducible factor and inducible nitric oxide synthase (iNOS), which increases the levels of intracellular RNS and ROS, resulting DNA damage in progression with poor prognosis. Furthermore, tumor-producing inflammation can induce nuclear factor-κB, resulting in iNOS-dependent DNA damage. Therefore, crosstalk between DNA damage and inflammation may play important roles in cancer development. A proposed mechanism for the crosstalk may explain why aspirin decreases the long-term risk of cancer mortality.Keywords
This publication has 88 references indexed in Scilit:
- Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumorsBMC Cancer, 2013
- The role of aspirin in cancer preventionNature Reviews Clinical Oncology, 2012
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trialsThe Lancet, 2012
- Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trialsThe Lancet, 2012
- Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesisProceedings of the National Academy of Sciences of the United States of America, 2011
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Inflammation and cancer: An ancient link with novel potentialsInternational Journal of Cancer, 2007
- Nanoparticles: pharmacological and toxicological significanceBritish Journal of Pharmacology, 2007
- Inflammation and cancerNature, 2002